ZofranLegal.com reports that recent Zofran lawsuits currently pending in Boston, Massachusetts now number 112. Filings report on the anti-nausea drug’s alleged connection to serious birth defects in developing babies. A report issued on November 16th, 2015 by the U.S. Panel on Multidistrict Litigation showed that the cases now number 112, although this number is expected to continue to rise. These cases are included in the current multidistrict litigation concerning Zofran, number 2657.
Zofran was developed by pharmaceutical giant GlaxoSmithKline, and was approved by the FDA in 1991 specifically to treat patients who were suffering from nausea and vomiting associated with chemotherapy, radiation, or anesthesia. The drug was never approved for or tested for safety on pregnant women, yet was allegedly marketed to this consumer group and to OB/Gyns across the nation by GSK. Since this time, it has been prescribed to an estimated 1 million pregnant women annually according to the American Journal of Obstetrics and Gynecology, and has become the topic of many lawsuits indicating that exposure to the drug through their mothers caused babies in the womb to develop birth defects.
MDL consolidation for the cases currently involved was originally established by the JPML on October 13th. Since this time all cases regarding Zofran birth defect lawsuits have been transferred to Boston, Massachusetts to join the MDL. The suits similarly allege that common birth defects connected to exposure to the drug in unborn babies are cleft lip and palate, atrial septal defect and ventricular septal defect, transposition of the greater vessels, and kidney defects. Several plaintiffs involved report that their infants were born with defects so severe they were fatal. Almost all plaintiffs note that their infants required multiple surgeries in an attempt to repair their defects.
The attorneys at Monheit Law have noted that this issue may affect many women and children across the nation. They are working to ensure that anyone who was prescribed Zofran while pregnant and who subsequently gave birth to a child with defects has the ability to evaluate their full legal rights. They are currently offering these individuals free consultations. Those involved may be entitled to legal action and substantial compensation.
To request additional information on Zofran birth defect lawsuits and the pending litigation, or to ask questions, please contact Attorney Michael Monheit of Monheit Law by calling (877) 620-8411.
###
Contact ZofranLegal.com:
Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046
